Updated antibiotic resistance and clinical spectrum of infections caused by Streptococcus pneumoniae in Taiwan: Emphasis on risk factors for penicillin nonsusceptibilities

Journal of Microbiology, Immunology and Infection

Volumn 46, Issue 5, 2013, Pages 345-351

  Tsai, Hsih Yeh ^a,b   Lauderdale, Tsai Ling ^c   Wang, Jann Tay ^a,c   Chen, Yao Shen ^d   Liu, Jien Wei ^e   Huang, Jeng Hwa ^f   Hu, Bor Hsian ^g   Yang, Chia Jui ^b   Lu, Daniel Chin Te ^h   Chang, Shan Chwen ^a,i  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f CATHAY GENERAL HOSPITAL   (Taiwan)

^g TAIPEI CITY HOSPITAL   (Taiwan)

^h LOTUNG POH AI HOSPITAL   (Taiwan)

ⁱ NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Antibiotic resistance; Penicillin nonsusceptibility; Streptococcus pneumoniae

Indexed keywords

COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PNEUMOCOCCAL INFECTION; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; TAIWAN;

ANTIBIOTIC RESISTANCE; PENICILLIN NONSUSCEPTIBILITY; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PREVALENCE; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE; TAIWAN; YOUNG ADULT;

EID: 84885189268     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.07.012     Document Type: Article

References (35)

1. Tleyjeh I.M., Tlaygeh H.M., Hejal R., Montori V.M., Baddour L.M. The impact of penicillin resistance on short-term mortality in hospitalized adults with Pneumococcal pneumonia: a systematic review and meta-analysis. Clin Infect Dis 2006, 42:788-797.
2. Trampuz A., Widmer A.F., Fluckiger U., Haenggi M., Frei R., Zimmerli W. Changes in the epidemiology of pneumococcal bacteremia in a Swiss university hospital during a 15-year period, 1986-2000. Mayo Clin Proc 2004, 79:604-612.
3. Lee C.Y., Chiu C.H., Huang Y.C., Chung P.W., Su L.H., Wu T.L., et al. Invasive pneumococcal infections: a clinical and microbiological analysis of 53 patients in Taiwan. Clin Microbiol Infect 2003, 9:614-618.
4. Wu T.T., Hsueh P.R., Lee L.N., Yang P.C., Luh K.T. Pneumonia caused by penicillin-nonsusceptible Streptococcus pneumoniae: clinical characteristics, prognostic factors, and outcomes. J Formos Med Assoc 2000, 99:18-23.
5. Hansman D., Bullen M.M. A resistant pneumococcus. Lancet 1967, 2:264-265.
6. Weinstein M.P., Klugman K.P., Jones R.N. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance. Clin Infect Dis 2009, 48:1596-1600.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 18th informational supplement. CLSI document M100-S18. Wayne, PA: CLSI; 2008.
8. Felmingham D., White A.R., Jacobs M.R., Appelbaum P.C., Poupard J., Miller L.A., et al. The Alexander Project: the benefits from a decade of surveillance. J Antimicrob Chemother 2005, 56(Suppl. S2). ii3-ii21.
9. Jones R.N., Sader H.S., Moet G.J., Farrell D.J. Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998-2009). Diagn Micr Infec Dis 2010, 68:334-336.
10. Chen Y.Y., Yao S.M., Chou C.Y., Chang Y.C., Shen P.W., Huang C.T., et al. Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002-2003. J Med Microbiol 2006, 55:1109-1114.
11. Fung C.P., Hu B.S., Lee S.C., Liu P.Y., Jang T.N., Leu H.S., et al. Antimicrobial resistance of Streptococcus pneumoniae isolated in Taiwan: an island-wide surveillance study between 1996 and 1997. J Antimicrob Chemother 2000, 45:49-55.
12. Ho M. Taiwan seeks to solve its resistance problems. Science 2001, 291:2550-2551.
13. Ho M., McDonald L.C., Lauderdale T.L., Yeh L.L., Chen P.C., Shiau Y.R. Surveillance of antibiotic resistance in Taiwan, 1998. J Microbiol Immunol Infect 1999, 32:239-249.
14. McDonald L.C., Lauderdale T.L., Shiau Y.R., Chen P.C., Lai J.F., Wang H.Y., et al. The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme, 2000. Int J Antimicrob Agents 2004, 23:362-370.
15. Clinical and Laboratory Standards Institute. Methods of dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 8th edition. CLSI document M07-A8. Wayne, PA: CLSI; 2009.
16. Low D.E. Changing trends in antimicrobial-resistant pneumococci: it's not all bad news. Clin Infect Dis 2005, 41(Suppl. 4):S228-S233.
17. Goossens H., Ferech M., Coenen S., Stephens P. European Surveillance of Antimicrobial Consumption Project Group. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis 2007, 44:1091-1095.
18. Fenoll A., Granizo J.J., Aguilar L. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol 2009, 47:1012-1020.
19. Gertz R.E., Li Z., Pimenta F.C., Jackson D., Juni B.A., Lynfield R., et al. Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis 2010, 201:770-775.
20. Hsieh Y.C., Wang J.T., Lee W.S., Hsueh P.R., Shao P.L., Chang L.Y., et al. Serotype competence and penicillin resistance in Streptococcus pneumoniae. Emerg Infect Dis 2006, 12:1709-1714.
21. Hsieh Y.C., Lin P.Y., Chiu C.H., Huang Y.C., Chang K.Y., Liao C.H., et al. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential. Vaccine 2009, 27:5513-5518.
22. Chang S.C. The strategies of restriction of antibiotic use and outcomes in Taiwan. Infect Control J 2003, 13:33-42.
23. Siira L., Rantala M., Jalava J. Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae isolates in Finland, 2002 to 2006. Antimicrob Agents Chemother 2009, 53:2066-2073.
24. Nava J.M., Bella F., Garau J., Lite J., Morera M.A., Marti C., et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994, 19:884-890.
25. Vanderkooi L.G., Low D.E., Green K., Powis J.E., McGeer A. Predicting antimicrobial resistance in invasive pneumococcal infection. Clin Infect Dis 2005, 40:1288-1297.
26. Guillemot D., Carbon C., Balkau B., Geslin P., Lecoeur H., Vauzelle-Kervroedan F., et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998, 279:365-370.
27. Clavo-Sanchez A.J., Giron-Gonzalez J.A., Lopez-Prieto D., Canueto-Quintero J., Sanchez-Porto A., Vergara-Campos A., et al. Multivariate analysis of risk factors for infection due to penicillin-resistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 1997, 24:1052-1059.
28. Bedos J.P., Chevret S., Chastang C., Geslin P., Regnier B. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin Infect Dis 1996, 22:63-72.
29. Chen C.J., Lin C.L., Chen Y.C., Wang C.W., Chiu C.H., Lin T.Y., et al. Host and microbiologic factors associated with mortality in Taiwanese children with invasive pneumococcal diseases, 2001 to 2006. Diagn Microbiol Infect Dis 2009, 63:194-200.
30. Yu V.L., Baddou L.M. Infection by drug-resistant Streptococcus pneumoniae is not linked to increased mortality. Clin Infect Dis 2004, 39:1087-1088.
31. Lin S.H., Liao W.H., Lai C.C., Tan C.K., Liao C.H., Huang Y.T., et al. Comparison of clinical features, antimicrobial susceptibility, serotype distribution and outcomes of patients with hospital- and community-associated invasive pneumococcal disease. Int J Antimicrob Agents 2010, 36:119-123.
32. Aspa J., Rajas O., Rodríguez de Castro F., Blanquer J., Zalacain R., Fenoll A., et al. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Clin Infect Dis 2004, 38:787-798.
33. Liao W.H., Lin S.H., Lai C.C., Tan C.K., Liao C.H., Huang Y.T., et al. Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan. Eur J Clin Microbiol Infect Dis 2010, 29:489-492.
34. Ogilvie I., Khoury A.E., Cui Y., Dasbach E., Grabenstein J.D., Goetghebeur M. Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions. Vaccine 2009, 27:4891-4904.
35. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374:893-902.